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ABSTRACT (278) 
 
Introduction. The simultaneous presence of type 2 diabetes (T2D) and metabolic 
syndrome exacerbates mortality risk. While exercise is often recommended for those 
with T2D, few studies have examined the effect of combining (AER+RES) aerobic 
(AER) and resistance (RES) training for individuals with T2D and metabolic syndrome.  
Methods. We examined 9 months of AER, RES, and AER+RES training 
commensurate with physical activity guidelines in individuals with T2D (N=262, 63% 
female, 44% black). The primary outcome was change in metabolic syndrome at 
follow-up (mean, 95% CI). Secondary outcomes included maximal cardiorespiratory 
fitness (VO2peak and time-to-exhaustion (TTE)) and exercise efficiency calculated as 
the slope of the line between ventilatory threshold, respiratory compensation, and 
maximal fitness. General linear models and bootstrapped Spearman correlations were 
used to examine changes in metabolic syndrome and exercise efficiency.  
Results. We observed a significant decrease in metabolic syndrome (p-for-trend, 
0.003) for AER (-0.59, 95% CI -1.00, -0.21) and AER+RES (-0.79, 95% CI -1.40, -
0.35); both being significant (P < 0.02) vs. Control (0.26, 95% CI -0.58, 0.40) and RES 
(-0.13, 95% CI -1.00, 0.24). Our observed decrease in metabolic syndrome was 
mediated by significant improvements in exercise efficiency for the AER and 
AER+RES training groups (P<0.05), which was more strongly related to TTE (r = -
0.38, 95% CI, -0.55, -0.19) than VO2peak (r = -0.24, 90% CI, -0.45, -0.01). Accordingly, 
VO2peak increased by 5-6%, while TTE increased by 25-30%. 
Conclusion. Aerobic and AER+RES training significantly improves metabolic 
syndrome in patients with T2D and appears to be mediated by improved exercise 
efficiency resulting in a greater TTE vs. increase in VO2peak. This observation may be 
useful in reconciling the results of epidemiology vs. clinical data when interpreting 
improved exercise capacity.  
 
Key Words. Metabolic syndrome, aerobic training, resistance training, exercise 
efficiency, Metabolic Equivalents (METs) 
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INTRODUCTION 
It is well recognized that metabolic syndrome is an independent risk factor for 
cardiovascular disease, diabetes, cancer and all-cause mortality.1 More importantly is 
the observation that individuals with type 2 diabetes (T2D) who present with coexisting 
metabolic syndrome are not only at a higher risk for respective morbidities, but show 
additional risk for each accrued metabolic syndrome component feature than those 
without T2D.2,3 ENREF3 Given the system wide physiological effects associated with 
exercise training, the continued advocacy for exercise training is of paramount 
importance for individuals presenting with T2D and metabolic syndrome 
simultaneously.  
 Research continues to show that a low percentage of individuals meet 
recommended physical activity guidelines throughout the world and that these statistics 
deteriorate as one transitions from childhood through adulthood and ageing.4 These 
statistics worsen in the presence of various disease states.4,5 Fundamental to most 
exercise recommendation statements is the advocacy for aerobic training (AER) and 
more recently, resistance training (RES).6 Resistance training is an important addition 
to healthcare as the combination of modalities (AER+RES) may be equally, if not more 
beneficial to health in some cases.7,8 In 2007, Sigal et al. demonstrated in the DARE 
Trial that AER+RES proved more beneficial for reducing HBA1c and some 
components associated with metabolic syndrome than AER alone.8 However, the time 
commitment associated with AER+RES training in DARE (270 min/wk) may be more 
than most individuals are willing to adopt given the low rates of exercise participation 
observed in most countries.9  
We recently reported in the HART-D Trial that an exercise intervention using 
the same treatment strategy as DARE, yet modelled for time commitment according to 
current exercise health recommendations, also demonstrated a greater reduction in 
HBA1c and increased maximal cardiorespiratory capacity (VO2peak) associated with 
AER+RES training.6,7 Mechanistically, we have also shown that AER+RES training in 
HART-D significantly improved several aspects of skeletal muscle mitochondrial 
content and substrate oxidation.10 While the primary outcome reports from DARE and 
HART-D examined various components of metabolic syndrome, neither study has 
undertaken an assessment of metabolic syndrome in its entirety. The analysis of 
metabolic syndrome is important given a recent report by Bateman et al. (2011) 
demonstrating that while RES training did not affect metabolic syndrome, AER and 
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AER+RES training decreased metabolic syndrome similarly in individuals who were 
sedentary, overweight, and dyslipidemic.11 These factors combined are of primary 
importance to patient care for individuals with T2D. A secondary challenge to these 
types of investigations is the attempt to reconcile modest, yet potentially important 
differences, between epidemiologic reports and clinical trial outcomes. 
Epidemiology trials examining maximal cardiorespiratory fitness (CRF) often 
report CRF in terms of Metabolic Equivalent Tasks or METs calculated at time-to-
exhaustion (TTE) due the inability to measure respiratory gas exchange in large trials. 
Based on epidemiology findings it has been estimated that an improvement in 1 MET 
carries with it a 13-19% reduction in all-cause and cardiovascular (CVD) mortality risk, 
respectively.12,13 We have recently demonstrated a dose dependent decrease in 
metabolic syndrome associated with fitness from the ACLS data set.14 Despite the 
protective effects of fitness found in epidemiology, clinical exercise trials show a 
smaller effect when equating exercise findings using METs calculated directly from 
VO2peak despite a more pronounced improvement in TTE within the same trial.
7,15 This 
disparity is important to consider as the true impact of clinical trials using VO2peak as a 
“gold standard” may not be fully appreciated. While the differences between directly 
measured and estimated METs can be posited objectively to differences in actual versus 
estimated METs, it is also conceivable that the difference between changes in VO2peak 
and TTE could be explained by improvements in exercise efficiency. 
The primary of aim of this analysis is to examine participants in the HART-D 
cohort to determine the relationship between AER, RES and AER+RES training and 
metabolic syndrome in participants with T2D.7 We hypothesize that metabolic 
syndrome will improve in a “dose-dependent” manner moving in order of effect from 
RES, to AER, to AER+RES training. Our secondary aim is to explore the relationship 
between metabolic syndrome and maximal fitness, whereby we propose that exercise 
efficiency will explain, in part, improvements in metabolic syndrome. 
 
METHODS 
The primary aim of the HART-D trial (N=262) was to examine the effect of 9-
months AER, RES and AER+RES training on HbA1c in participants with T2D.7 
Volunteers presented to HART-D as sedentary men and women (30-75 y) with T2D 
(HbA1C = 6.5% - 11.0%). We defined sedentary behavior as performing AER exercise 
< 20 minutes on < 3 days per week and not participating in RES. Individuals were 
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excluded for the presence of or medical history of stroke, advanced neuropathy or 
retinopathy, or other serious medical condition contraindicated for exercise or that may 
prevent adherence to the study protocol. The Pennington Biomedical Research Center 
institutional review board approved the HART-D study annually, and written consent 
was obtained from all participants prior to study screening. All study procedures were 
performed in accordance with the Declaration of Helsinki.  
Study Design and Intervention 
 Volunteers who met inclusion criteria were randomized to AER, RES, or 
AER+RES, or a non-exercise control group (Control). During the study, we maintained 
separate intervention and assessments teams and clinical testing and intervention 
laboratories were housed in separate buildings. During the course of the trial, 
participants met with a certified diabetes educator each month to track medication and 
health history changes and all exercise sessions were constantly monitored by trained 
study staff. The Control group was offered weekly stretching and relaxation classes. 
Participants randomized to the Control group were asked to maintain their normal daily 
physical activity level throughout the intervention. We confirmed physical activity 
levels using step counters. The stretching and relaxation classes were optional and 
considered light intensity physical activity inadequate to influence CRF or produce 
significant increases in strength. It should be noted, however, that during the course of 
the study, data safety monitoring procedures caused us to discontinue the Control group 
after a significant number of participants (~17%) had an increase in HbA1C > 1.0%, 
resulting in an unequal number of participants in the Control group. 
 The AER and AER+RES groups participated in treadmill walking 3 - 5 days 
per week at a moderate to vigorous intensity (65.4 ± 14.6% of peak oxygen 
consumption; VO2peak, mean ± SD). The exercise dose in the AER group was prescribed 
at 12 kcal per kg body weight per week (KKW), which was estimated to be equivalent 
to ~150 min/wk. Participants were weighed weekly to calculate the prescribed weekly 
caloric energy expenditure rate estimated from standard equations published by the 
American College of Sports Medicine.6,16 The time required per session was calculated 
by dividing the weekly dose by the estimated caloric expenditure rate and the total 
number of sessions completed that week. The AER dose was lowered to 10 KKW in 
the AER+RES group to accommodate the RES component and ensure equal time 
commitment across all exercise groups. 
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 The RES group completed 3 days of strength training exercises per week 
consisting of 2 sets of 4 upper body exercises (bench press, seated row, shoulder press, 
and lat pull down), 3 sets of 3 lower body exercises (leg press, extension, and flexion), 
and 2 sets of abdominal crunches and back extensions. Each set consisted of 10-12 
repetitions and the amount of weight lifted was progressively increased once a 
participant was able to complete 12 repetitions on the final set of an exercise on 2 
consecutive RES sessions. Participants in the AER+RES group completed 2 sessions 
of RES each week consisting of 1 set of 10-12 repetitions for all resistance exercises. 
Measurements 
Metabolic syndrome and Cardiorespiratory Capacity. The primary outcome for our 
analysis is metabolic syndrome as defined by NCEP ATP III guidelines.1 
Cardiorespiratory fitness was evaluated using a standardized, ECG monitored, 
treadmill test while simultaneously collecting respiratory gases sampled from a True 
Max 2400 Metabolic Measurement Cart (ParvoMedics, Salt Lake City, Utah). From 
this test we measured peak oxygen VO2peak and time-to-exhaustion (TTE), subsequently 
METs as (1) as VO2peak in ml/kg/min divided by 3.5 and (2) according to ACSM 
calculations based on speed and grade obtained at the end of exercise testing.17 Our 
rational for examining VO2peak and TTE is based on our desire to detail the 
clinical/physiologic changes surrounding VO2peak and the epidemiological index of 
time-to-exhaustion, as well as ascertaining exercise efficiency (detailed below).  
To examine exercise efficiency we first calculated ventilatory threshold 1 (VT1) 
using the v-slope method by plotting VO2 and VCO2 on the x- and y-axes, respectively, 
and visually examining the slope of the relationship for a breakpoint in linearity.18 We 
also calculated the respiratory compensation point attained during each test as an 
increase in the ventilatory equivalent of oxygen (VE/VO2) and end-tidal partial pressure 
of oxygen (PETO2) with no concomitant increase in the ventilatory equivalent of carbon 
dioxide (VE/VCO2) to confirm these findings. It should be noted that within the 
literature, respiratory compensation is also referred to ventilatory threshold 2 (VT2).19 
For consistency we will use VT2. To determine exercise efficiency, we calculated the 
slope of the line between the time of onset of VT1, VT2, and TTE. 
Blood Chemistries and Anthropometric Measures 
Hemoglobin A1C (HbA1C) was obtained by venipuncture after a 10-h fast and analyzed 
with a Beckman Coulter DXC600 Pro (Brea, CA). Weight was measured on a GSE 450 
electronic scale (GSE Scale Systems, Novi, Michigan) and height was measured using 
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a standard stadiometer. Body mass index was calculated as follow: body weight 
(kg)/height (m2). Waist circumference was measured to the nearest 0.1 cm at the level 
of the iliac crest while the subject was at minimal expiration. Body composition was 
measured by dual-energy x-ray absorptiometry using the QDR 4500A whole-body 
scanner (Hologic Inc., Bedford, MA).  
Statistical Methods. 
 The primary outcome for our analysis is metabolic syndrome. For secondary 
outcomes we examined changes in respective metabolic syndrome component versus 
between the components features of metabolic syndrome (list them here?) and METs 
derived from VO2peak and TTE. For exploratory purposes, we also examined the 
relationship between exercise efficiency and metabolic syndrome. For our primary and 
secondary analyses we used a generalized linear model to analyse the influences of the 
differing doses of exercise training on metabolic syndrome (SPSS version 21.0, 
Somers, NY). Relationships for our tertiary analysis were performed using a Spearman 
correlation analysis for changes in metabolic syndrome versus changes 
cardiorespiratory fitness, metabolic syndrome components, and anthropometry indices 
as independent variables. For this latter analysis, we performed a bootstrap analysis of 
our data using 1,000 imputations. Bootstrapping was used in order to improve the 
accuracy of confidence intervals surrounding various correlations as we reasoned that 
(1) our cohort continued their medication use during the study and (2) owing to our 
original report, the participants in our study reduced medication use concurrent with 
exercise training.7 Subsequently, any change in medication use surrounding metabolic 
syndrome components would likely influence our analysis effectively reducing the 
magnitude of the amount of changes in metabolic syndrome.  
Based on our primary outcome paper, all of our analyses were covaried for age, 
ethnicity, duration of diabetes, baseline HbA1c, and baseline and follow-up 
medications used for diabetes, blood pressure, and cholesterol. We also included 
baseline metabolic syndrome score within this analysis. Within group differences 
between baseline and follow-up are reported as mean and 95% confidence intervals 
(95% CI). When we observed significant trends, we further explored our findings using 
a priori comparisons between each exercise-training group vs. the Control group via 
Dunnett-Hsu post-hoc assessments. All reported P-values are two-sided (P<0.05) and 
our report accounts for Dunnett-Hsu adjustments when reported. Data are presented as 
Mean ± SD or mean change from baseline and 95% confidence intervals as appropriate.  
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RESULTS  
The demographic characteristics and clinical features of our cohort (N = 262) are 
presented in Table 1. For our exploratory analyses of exercise efficiency we 
successfully examined 207 participants who had complete data for each variable 
examined. No significant differences were observed for maximal fitness characteristics 
or percentage presenting with metabolic syndrome between the entire cohort and our 
tertiary assessment so we have presented all fitness characteristics in Table 2. Overall, 
participants presented with an average age of 56 ± 9 y and diabetes duration of 7.1 ± 
5.5 y. Based on BMI (34.9 ± 5.9 kg/m2) participants in our study ranged from class I to 
class III obese.  
 Based on VO2peak (20.1 ± 4.3 ml/kg/min) participants in HART-D were low fit, 
ranking in the lower 15th percentile for maximal cardiorespiratory capacity achieved 
during exercise testing.17,20_ENREF_15 These levels correspond to the Class I/II fitness 
levels as defined by the New York Heart Association.21 Fifty-nine percent of our cohort 
presented with metabolic syndrome at baseline. Sixty three percent of our cohort were 
women, 44% black, 3% Asian and 0.5% Hispanic. Ninety-seven percent of our cohort 
used diabetes medications, 79% blood pressure medications and 64% cholesterol 
medications at baseline.  
Metabolic syndrome. We have presented the results of our metabolic syndrome analysis 
in Figure 1 where we observed a significant trend (P = 0.003) for a decrease in 
metabolic syndrome within the AER (-0.49, 95% CI -0.77, -0.21) and AER+RES (-
0.64, 95% CI -0.92, -0.35) groups. Both of these findings were significant (P < 0.02) 
vs. Control (0.03, 95% CI -0.33, 0.40) and RES (-0.03, 95% CI -0.30, 0.24).  
For our analysis of metabolic syndrome components, we observed a significant 
trend (P < 0.03) for reduced waist circumference improvement for all treatment groups: 
RES (-1.91 cm; 95% CI,  -3.03, -0.78), AER (-1.58 cm; 95% CI,  -2.76, -0.39), and 
AER+RES (-2.80 cm; 95% CI, -3.93, -1.67), with all treatment groups being significant 
vs. Control (0.67 cm; 95% CI, -0.82, 2.15), P < 0.05). We also observed a significant 
reduction in systolic blood pressure for the AER group (-6.61 mmHg; 95% CI -6.00, -
0.22), also significant vs. Control (P < 0.05). No other metabolic syndrome features 
were found to be significant.  
Maximal Cardiorespiratory Capacity. Participants presented at baseline with an 
absolute VO2peak of 1.92 ± 0.5 L and relative VO2peak of 20.1 ± 4.3 ml/kg/min. This 
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equated to a measure maximal MET capacity of 5.8 ± 1.2. Time-to-exhaustion during 
treadmill testing was 641 ± 151 seconds or approximately 10.7 ± 2.5 minutes. This 
equates to 8.57 ± 1.3 estimated METs. The mean METs measured from VO2peak were 
5.75 ± 1.2 and significantly lower than METs estimated from speed and grade at TTE 
(P < 0.05).  
After 9 months of exercise training we observed a 5-6% increase in METs 
measured by gas exchange vs. a 25-30% increase in METs estimated from speed and 
grade. For measured METs, we observed minor; yet, significant increases in the AER 
and AER+RES training (Fig. 2). However, no between group differences were 
otherwise noted. For estimated METs, we also observed significant increases in the 
AER and AER+RES training groups that were (a) significantly different than measured 
METs and (b) significantly different than respective measured METs (P < 0.05; Fig. 
2).  
METs obtained directly from VO2peak were: Control (-0.09, 95% CI, -0.28, 
0.11), RES (0.00, 95% CI, -0.14, 0.17), AER (0.14, 95% CI, 0.02, 0.28), AER+RES 
(0.29, 95% CI, 0.14, 0.42). METs calculated from speed and grade were: Control (-
0.25, 95% CI, -0.66, 0.15), RES (0.12, 95% CI, -0.19, 0.42), AER (1.04, 95% CI, 0.71, 
1.36), and AER+RES (1.30, 95% CI, 1.01, 1.61), with the AER and AER+RES being 
significantly greater than Control and RES (P <0.05).  
Time-to-exhaustion following exercise training decreased in the Control 
group (-28 sec; 95% CI -76, 20) and showed a small increase for the RES (13 sec; 95% 
CI -23, 49) training group. Neither of these changes was statistically significant. 
However, a significant increase in TTE was observed for the AER (119 sec; 95% CI 
81, 157) and AER+RES (154 sec; 95% CI 118, 189) training groups, with both being 
significant vs. Control and RES groups (P < 0.05; Fig. 3a).  
Sub-maximal Cardiorespiratory Indices and Exercise Efficiency. Similar observations 
to TTE were noted for the time-to-onset of VT1 (Fig. 3b) and VT2 (Fig. 3c). However, 
while VT1 improved in all treatment groups, VT2 improved only in the AER and 
AER+RES training groups compared to baseline. Specifically, VT1 (Fig. 3b) did not 
improve in the Control group (9.0 sec; 95% CI -29, 47), but significantly increased in 
all treatment groups: RES (51 sec; 95% CI, 5, 63); AER (34 sec; 95% CI 22, 80); 
AER+RES, (89 sec; 95% CI, 61, 117).  For VT2 (Fig. 3c), no significant improvements 
were noted for the Control, (6 sec, 95% CI, -44, 56) or RES (28 sec; 95% CI, -11, 68) 
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groups, but were significant for the AER (91 sec; 95% CI, 50, 133) and AER+RES (163 
sec; 95% CI 123, 203) groups (Fig. 3b). The net effect of these changes was a rightward 
shift in the slope of the relationship between from baseline to follow-up for VT1, VT2 
and TTE where no significant improvements were observed for the Control group (Fig. 
3d). The changes for the AER and AER+RES training groups were both significant vs. 
the Control and RES training groups (P<0.05). The net effect of these changes is 
schematically represented for the entire cohort in Figure 4. Lastly, our analysis showed 
significant correlations for changes between metabolic syndrome, TTE (r = -0.33, 95% 
CI -0.49, -0.15), VO2peak (r = -0.24, 95% -0.36, -0.05), and waist circumference (r = -
0.14, 95% -0.11, -0.40). No other significant relationships were noted for other indices 
of body anthropometry.  
 
DISCUSSION. 
The primary findings from our current study show that AER and AER+RES training 
effectively reduce metabolic syndrome in individuals with T2D. Though the magnitude 
of treatment effects was not “dose dependent,” per se, the AER+RES training arm of 
our study did show a modest tendency for improvement larger reduction in metabolic 
syndrome score. This difference, however, was not statistically different. What is 
notable is that AER+RES performed in accordance with contemporary exercise 
guidelines as an effective strategy for reducing metabolic syndrome scores in 
individuals with T2D and should be considered as a viable treatment schema. When 
examined as individual metabolic syndrome component features, we also found that 
waist circumference was significantly reduced in all exercise groups, while systolic 
blood pressure was significantly reduced only in the AER group. No other significant 
component feature reductions were noted for metabolic syndrome. These findings are 
clinically important to individuals who present with T2D, low CRF, and metabolic 
syndrome simultaneously.  
Previous research shows a greater CVD and all-cause mortality risk for 
individuals who have coexisting metabolic syndrome and T2D.2,3 In 2006, Guzder et 
al. (2006) demonstrated that age, sex, smoking status, total cholesterol, antiplatelet 
therapy, antihypertensive therapy, and lipid lowering therapy adjusted survival curves 
in patients with conjoint metabolic syndrome and T2D exhibited a  hazard ratio (HR) 
for incident CVD of 2.05 compared to individuals with T2D alone. Under the 
assumption that the presence of T2D qualified all participants with a minimum of one 
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metabolic syndrome feature, compounding risk was also observed for the accretion of 
two (HR, 1.93 ± 0.39), three (HR 2.71 ± 0.18), four (HR, 4.23 ± 0.56), and five (HR, 
4.76 ± 0.042) metabolic syndrome component features. Najarian et al. (2006) have also 
shown in data obtained from the Framingham Study that the relative risk of stroke in 
individuals with diabetes and metabolic syndrome is approximately 32%-55% higher 
than those individuals presenting with diabetes or metabolic syndrome alone.3 Previous 
reports from our group in men show similar findings.22 In a prospective report from the 
Aerobics Center Longitudinal Study, we found that CVD deaths were higher in 
individuals with diabetes alone (5.5/1,000 man years; HR; 2.9, 95% CI 2.1– 4.0) and in 
combination with metabolic syndrome (6.5/1,000 man years; HR; 3.4 95% CI 2.8–4.2) 
vs. men without diabetes or metabolic syndrome (1.9/1,000 man years) or metabolic 
syndrome only (3.3/1,000 man years; HR; 1.8, 95% CI 1.5–2.0).22  
Epidemiology trials also demonstrate that AER and RES are inversely and 
independently associated with metabolic syndrome.14,23,24 While clinical exercise 
intervention trials also support the efficacy of AER or RES training for reducing 
metabolic syndrome, less is known about combining AER+RES training, especially for 
those presenting with T2D and metabolic syndrome. A difficulty in interpreting the 
current literature with regard to the RES training aspect of metabolic syndrome is a 
relative paucity of trials examining RES training on metabolic syndrome versus 
examining the role of RES on the individual component features of metabolic 
syndrome. This difficulty is exemplified in a recent systematic and meta-analysis by 
Strasser et al. (2010), who examined 13 trials involving RES and metabolic syndrome. 
While the authors provided an excellent review of RES training on the component 
features of metabolic syndrome they did not, or were unable to, account metabolic 
syndrome as a composite score. Fewer reports still have examined the effect of 
AER+RES training in metabolic syndrome. 
Similar in nature to HART-D, Sigal et al. reported in the DARE trial, significant 
reductions in HBA1c coinciding with AER, RES and AER+RES training.8 Despite the 
reporting of metabolic syndrome composite features, no further analysis was 
undertaken to examine metabolic syndrome itself. To date, only the study of Bateman 
et al. (20011) have examined the effects of AER+RES on metabolic syndrome in 
participants from the STRIDDE study.11 Though STRIDDE did not examine 
individuals with T2D, they demonstrated similar effects to our current report in a 
convenience sample of 84 out of 196 individuals presenting with all five NCEP ATP 
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III defined metabolic syndrome components. Specifically, participants partaking in 
AER and AER+RES training decreased metabolic syndrome, while those undertaking 
RES and Control conditions showed no reduction. Overall, the findings of HART-D 
and STRIDDE demonstrate that AER and AER+RES training are equally effective for 
reducing metabolic syndrome in T2D and non-diabetic individual, respectively.  
 Mechanistically, the effects of exercise on metabolic syndrome are related to 
changes in a number of physiologic and cardiovascular adaptations to exercise training. 
Physiologically, the effects of exercise training on the component features of metabolic 
syndrome have been thoroughly reviewed elsewhere and are not elaborated on 
here.(ref) However, an underlying question we posed when undertaking our current 
analysis was to examine potential differences between clinical trials that rely on 
laboratory measure of VO2peak and epidemiologic trials that typically use TTE and 
corresponding MET values. One of the features we observed in some of our trials, 
inclusive of HART-D, was a disparity between the relative increase in measured 
VO2peak and TTE.(ref) In our current analysis, we observed a significant difference 
between MET values measured from VO2peak (5-6%) and TTE (25-30%), with the latter 
showing a stronger relationship with metabolic syndrome. It is easy to rationalize this 
apparent inequality in terms of the mathematical variance associated with estimating 
METs from an equation based on speed and grade versus the actual measurement of 
VO2peak. This disparity, however, makes it difficult to reconcile epidemiology and 
clinical trials as data from epidemiology trials suggest a 13% and 15% reduction in all-
cause and CVD risk mortality, respectively, for each MET attained during exercise 
testing.13 Rather than assume that the difference between the two measures was simply 
a matter of the mathematical variance introduced with prediction equations, we 
hypothesized that some of this disparity could be explained by improvements in 
exercise efficiency.   
 Our findings showing significant, yet higher correlations for TTE and VO2peak 
are intriguing. Though both measurements detail “maximal cardiorespiratory capacity,” 
per se and may covary to some degree, they also reflect differences in the physiologic 
response to graded exercise testing. While VO2peak reflects changes in measured 
cardiorespiratory capacity, which, in and of itself is a reflection maximal cardiac output 
and muscle oxygen utilization, TTE may reflect an improvement in sub-maximal 
exercise efficiency. Unfortunately, little data exists examining this relationship. 
Numerous methods have been proposed to measure exercise efficiency in athletic and 
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clinical populations including mechanical efficiency, gross efficiency, delta efficiency, 
oxygen uptake efficiency slope, and others.25-29 While all of these methods have their 
strengths and weaknesses, each measure is largely dependent on a single point of 
observation or the slope of the changing relationship between the oxygen uptake of 
sequential stages, and hence, the workload involved in exercise testing.  
 In a classic experiment, Beaver et al. (1986) demonstrated that “anaerobic 
threshold” could be determined by the ventilatory threshold or V-slope method, which 
examines the departure from linearity between carbon dioxide (VCO2) and oxygen 
uptake (VO2).19 In the same study, the authors also describe a second break point 
occurring in the latter stages of exercise testing between minute ventilation (Ve) and 
VCO2. For simplicity we will hereafter refer to these break points as VT1 and VT2, 
respectively, where VT1 represents the first rise in blood lactate concentration leading 
to a disproportionate increase in carbon dioxide 30,31 and VT2 due to a respiratory 
compensation reflecting an exercise induced hyperventilation and an increase in minute 
ventilation relative to carbon dioxide.26,27,18  For our analysis we examined the slope of 
the relationship between VT1, VT2 and maximal exercise, finding that the slope of this 
relationship improved in the AER and AER + RES groups and that these changes were 
more strongly related to TTE than measured VO2peak. From these data, we conclude that 
exercise training improves the underlying physiology encumbered during exercise 
testing and that these improvements equate to an improvement in TTE, and 
subsequently, partially explain the difference between estimated METs vs. those 
obtained from laboratory derived VO2peak.  
 A primary strength of HART-D is that it was a highly controlled clinical 
exercise intervention lasting 9-months. Our study is limited in its generalizability to 
those with T2D. Still, findings from STRIDDE suggest that the findings are similar in 
those without diabetes. It might also be argued that the degree of medical supervision 
(i.e., prescriptive medications) surrounding our cohort could introduce uncontrollable 
statistical variance into our reported outcomes. From a clinical perspective, we have 
accounted for changes in medication within our statistical analysis by using baseline 
and follow-up medication use. This, in turn, strengthens our findings, as they are 
standard measures of clinical care and patient healthcare management. One of the 
strongest features of our study is that it was designed to emulate current public guideline 
statements for exercise. Taken in combination our results show that AER or AER+RES 
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training plays an important role in the management of individuals with T2D who also 
present with sufficient qualifying components to also have metabolic syndrome.  
 
   
 15 
Disclosures 
 
Dr. Church receives honoraria for lectures from scientific, educational, and lay groups. 
Dr. Church has a book entitled “Move Yourself: The Cooper Clinic Medical Director’s 
Guide to All the Healing Benefits of Exercise.” Dr. Church has received research 
funding from the American Heart Association and the National Institutes of Health as 
well as unrestricted research funding from Coca-Cola. Dr. Church has overseen study 
sites for large pharmaceutical trials funded by Sanofi Aventis, Orexigen, Arena and 
Amylin. Dr. Church is a member of the Jenny Craig Medical Advisory Board and has 
served as a consultant to Technogym, Trestle Tree, Vivus, Lockton-Dunning and 
Neuliven Health. In addition, he serves as the Senior Medical Advisor for Catapult 
Health  
 
No other disclosures are otherwise noted. 
  
 16 
FIGURE LEGENDS 
 
Figure 1. Represents changes in categorical metabolic syndrome scores from baseline 
to follow-up. Data are Mean ± 95% CI. Statistical significance is noted as: a Aerobic 
vs. Control, P = 0.028; b Aerobic vs. Resistance, P = 0.02; c Aerobic+Resistance vs. 
Control, P = 0.005; d Aerobic+Resistance vs. Resistance, P = 0.003. 
 
Figure 2. Data represent changes in waist circumference and systolic blood pressure 
from baseline to follow-up. Data are Mean ± 95% CI. Statistical significance is noted 
as: a Aerobic vs. Control, p = 0.028. 
 
Figure 3. Data represent changes in diastolic blood pressure, fasting glucose, 
triglycerides and HDL-C from baseline to follow-up. Data are Mean ± 95% CI. 
 
  
 17 
REFERENCES. 
1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic 
syndrome: a joint interim statement of the International Diabetes 
Federation Task Force on Epidemiology and Prevention; National Heart, 
Lung, and Blood Institute; American Heart Association; World Heart 
Federation; International Atherosclerosis Society; and International 
Association for the Study of Obesity. Circulation. Oct 20 
2009;120(16):1640-1645. 
2. Guzder RN, Gatling W, Mullee MA, Byrne CD. Impact of metabolic syndrome 
criteria on cardiovascular disease risk in people with newly diagnosed type 
2 diabetes. Diabetologia. Jan 2006;49(1):49-55. 
3. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB, Wolf PA. 
Metabolic syndrome compared with type 2 diabetes mellitus as a risk 
factor for stroke: the Framingham Offspring Study. Archives of internal 
medicine. Jan 9 2006;166(1):106-111. 
4. Matthews CE, Chen KY, Freedson PS, et al. Amount of time spent in 
sedentary behaviors in the United States, 2003-2004. American journal of 
epidemiology. Apr 1 2008;167(7):875-881. 
5. King AC, Blair SN, Bild DE, et al. Determinants of physical activity and 
interventions in adults. Medicine and science in sports and exercise. Jun 
1992;24(6 Suppl):S221-236. 
6. American College of Sports Medicine Position Stand. The recommended 
quantity and quality of exercise for developing and maintaining 
cardiorespiratory and muscular fitness, and flexibility in healthy adults. 
Medicine and science in sports and exercise. Jun 1998;30(6):975-991. 
7. Church TS, Blair SN, Cocreham S, et al. Effects of aerobic and resistance 
training on hemoglobin A1c levels in patients with type 2 diabetes: a 
randomized controlled trial. JAMA. Nov 24 2010;304(20):2253-2262. 
8. Sigal RJ, Kenny GP, Boule NG, et al. Effects of aerobic training, resistance 
training, or both on glycemic control in type 2 diabetes: a randomized trial. 
Annals of internal medicine. Sep 18 2007;147(6):357-369. 
9. Bauman A, Bull F, Chey T, et al. The International Prevalence Study on 
Physical Activity: results from 20 countries. The international journal of 
behavioral nutrition and physical activity. 2009;6:21. 
10. Sparks LM, Johannsen NM, Church TS, et al. Nine months of combined 
training improves ex vivo skeletal muscle metabolism in individuals with 
type 2 diabetes. The Journal of clinical endocrinology and metabolism. Apr 
2013;98(4):1694-1702. 
11. Bateman LA, Slentz CA, Willis LH, et al. Comparison of aerobic versus 
resistance exercise training effects on metabolic syndrome (from the 
Studies of a Targeted Risk Reduction Intervention Through Defined 
Exercise - STRRIDE-AT/RT). The American journal of cardiology. Sep 15 
2011;108(6):838-844. 
12. Lee DC, Sui X, Artero EG, et al. Long-term effects of changes in 
cardiorespiratory fitness and body mass index on all-cause and 
cardiovascular disease mortality in men: the Aerobics Center Longitudinal 
Study. Circulation. Dec 6 2011;124(23):2483-2490. 
13. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a 
quantitative predictor of all-cause mortality and cardiovascular events in 
 18 
healthy men and women: a meta-analysis. JAMA. May 20 
2009;301(19):2024-2035. 
14. Earnest CP, Artero EG, Sui X, Lee DC, Church TS, Blair SN. Maximal 
Estimated Cardiorespiratory Fitness, Cardiometabolic Risk Factors, and 
Metabolic Syndrome in the Aerobics Center Longitudinal Study. Mayo Clinic 
proceedings. Mayo Clinic. Feb 2 2013. 
15. Church TS, Earnest CP, Skinner JS, Blair SN. Effects of different doses of 
physical activity on cardiorespiratory fitness among sedentary, overweight 
or obese postmenopausal women with elevated blood pressure: a 
randomized controlled trial. JAMA. May 16 2007;297(19):2081-2091. 
16. Albright A, Franz M, Hornsby G, et al. American College of Sports Medicine 
position stand. Exercise and type 2 diabetes. Med Sci Sports Exerc. 
2000;32(7):1345-1360. 
17. ACSM's Guidelines for Exercise Testing and Prescription. Eight ed: Lippincott 
William & Wilkins; 2010. 
18. Sun XG, Hansen JE, Garatachea N, Storer TW, Wasserman K. Ventilatory 
efficiency during exercise in healthy subjects. American journal of 
respiratory and critical care medicine. Dec 1 2002;166(11):1443-1448. 
19. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic 
threshold by gas exchange. J Appl Physiol. Jun 1986;60(6):2020-2027. 
20. Obesity: preventing and managing the global epidemic. Report of a WHO 
consultation. World Health Organization technical report series. 
2000;894:i-xii, 1-253. 
21. Fletcher GF, Ades PA, Kligfield P, et al. Exercise Standards for Testing and 
Training: A Scientific Statement From the American Heart Association. 
Circulation. Jul 22 2013. 
22. Church TS, Thompson AM, Katzmarzyk PT, et al. Metabolic syndrome and 
diabetes, alone and in combination, as predictors of cardiovascular disease 
mortality among men. Diabetes care. Jul 2009;32(7):1289-1294. 
23. Brage S, Wedderkopp N, Ekelund U, et al. Features of the metabolic 
syndrome are associated with objectively measured physical activity and 
fitness in Danish children: the European Youth Heart Study (EYHS). 
Diabetes care. Sep 2004;27(9):2141-2148. 
24. Jurca R, Lamonte MJ, Church TS, et al. Associations of muscle strength and 
fitness with metabolic syndrome in men. Medicine and science in sports and 
exercise. Aug 2004;36(8):1301-1307. 
25. Moseley L, Jeukendrup AE. The reliability of cycling efficiency. Medicine and 
science in sports and exercise. Apr 2001;33(4):621-627. 
26. de Koning JJ, Noordhof DA, Lucia A, Foster C. Factors affecting gross 
efficiency in cycling. Int J Sports Med. Nov 2012;33(11):880-885. 
27. Lucia A, Hoyos J, Perez M, Santalla A, Chicharro JL. Inverse relationship 
between VO2max and economy/efficiency in world-class cyclists. Medicine 
and science in sports and exercise. Dec 2002;34(12):2079-2084. 
28. Lucia A, San Juan AF, Montilla M, et al. In professional road cyclists, low 
pedaling cadences are less efficient. Medicine and science in sports and 
exercise. Jun 2004;36(6):1048-1054. 
29. Baba R, Nagashima M, Goto M, et al. Oxygen uptake efficiency slope: a new 
index of cardiorespiratory functional reserve derived from the relation 
between oxygen uptake and minute ventilation during incremental 
 19 
exercise. Journal of the American College of Cardiology. Nov 15 
1996;28(6):1567-1572. 
30. Wasserman K, Beaver WL, Whipp BJ. Gas exchange theory and the lactic 
acidosis (anaerobic) threshold. Circulation. Jan 1990;81(1 Suppl):II14-30. 
31. Whipp BJ, Ward SA, Wasserman K. Respiratory markers of the anaerobic 
threshold. Advances in cardiology. 1986;35:47-64. 
 
 
